Successful Treatment of Severe Myocardial Injury Complicated With Refractory Cardiogenic Shock Caused by AOPP Using Extracorporeal Membrane Oxygenation

Yang Li, Chunshui Cao, Xiaolong Luo, Huang LiangResearch 2020 · DOI

TL;DR

This case report demonstrates that Veno-Arterial Extracorporeal Membrane Oxygenation (VA-ECMO) can serve as a life-saving "bridge to recovery" for patients suffering from severe heart failure due to acute organophosphate pesticide poisoning (AOPP). By providing mechanical circulatory support, VA-ECMO allows the heart to rest and recover from reversible toxic damage that would otherwise be fatal.

What Problem Does This Paper Address?

Acute organophosphorus pesticide poisoning (AOPP) is a major clinical challenge, particularly in agricultural regions, with a global mortality rate often exceeding 15%. While many associate organophosphates primarily with respiratory failure (due to the "cholinergic crisis"), severe cases often involve profound cardiotoxicity.

When AOPP leads to refractory cardiogenic shock—a state where the heart is so damaged it cannot pump enough blood to sustain the body—the mortality rate skyrockets to over 60%. Standard treatments like atropine, oximes, and fluid resuscitation often fail in these extreme cases. The authors address the need for an aggressive intervention strategy to support the cardiovascular system while the body clears the toxins and the myocardium (heart muscle) heals.

Methods

The paper describes a clinical intervention for a 43-year-old female patient who ingested 300 ml of phoxim pesticide. After traditional therapies (intubation, hemoperfusion, atropine, and high-dose vasopressors) failed to stabilize her deteriorating hemodynamic state, the medical team initiated VA-ECMO.

VA-ECMO is a form of temporary life support that uses a pump to circulate blood through an artificial lung (oxygenator) and back into the arterial system, effectively bypassing the heart and lungs. This differs from standard supportive care by providing active mechanical circulation, allowing the heart to "rest" during the peak of toxic injury.

Datasets

As this is a clinical Case Report, there is no large-scale dataset or training corpus. The "data" consists of the individual patient’s longitudinal clinical metrics, including:

  • Electrocardiograms (ECG): Monitoring ST-segment changes and arrhythmias.
  • Cardiac Biomarkers: Measuring levels of Troponin I (cTnI) and NT-ProBNP to quantify muscle damage and heart strain.
  • Echocardiography: Measuring the Left Ventricular Ejection Fraction (LVEF) to assess pumping efficiency.

Key Insights and Ideas

  • Reversibility of Toxic Injury: The core "aha moment" is the reinforcement that AOPP-induced heart damage—including interstitial edema and ischemia—is often reversible. If the patient can be kept alive through the acute phase, the heart can regain function.
  • The "Bridge" Concept: ECMO does not treat the poisoning itself; rather, it acts as a bridge. It provides the hemodynamic stability necessary for the patient to survive the time required for pesticide metabolism and myocardial inflammation to subside.
  • Multifaceted Toxicity: The paper highlights that AOPP damages the heart through four distinct pathways:
  • Direct toxic effects of the pesticide and its solvents.
  • Autonomic dysfunction (a "catecholamine storm" causing coronary spasms).
  • Acetylcholine accumulation leading to toxic myocarditis.
  • Secondary damage from respiratory failure and metabolic acidosis.

Key Results

The intervention led to a successful recovery in a high-risk scenario:

  • Rapid Stabilization: Just three hours after starting ECMO, the patient's ECG showed a decrease in ST-segment elevation. Hemodynamics improved within six hours.
  • Functional Recovery: The patient’s ejection fraction (a measure of heart strength) improved from a critical 30% at the time of shock to 46% by the third day of ECMO.
  • Successful Decannulation: The patient was successfully removed from ECMO support on day 3, transferred out of the ICU on day 11, and discharged fully recovered on day 25.
  • Biomarker Normalization: Laboratory results showed a significant decrease in cardiac enzymes (cTnI and CK-MB) following the initiation of support.

Limitations and Future Work

The primary limitation is that this is a single-patient case report (N=1). While the results are compelling, they do not constitute a randomized controlled trial. ECMO is also an extremely resource-intensive, expensive, and high-risk procedure that requires specialized teams and can lead to complications like bleeding or infection.

The authors suggest that future work should focus on establishing clearer clinical guidelines for the "early application" of ECMO in poisoning cases. Specifically, identifying the exact window where conventional therapy is deemed "failed" but before multi-organ failure becomes irreversible is crucial for improving survival rates across larger populations.

Summary updated

Abstract

Abstract Acute organophosphorus pesticide poisoning (AOPP) is a common critical illness observed in clinical practice, and severe AOPP can cause serious cardiac toxicity. We report a case of severe myocardial injury caused by AOPP complicated with refractory cardiogenic shock that was successfully rescued with veno-arterial extracorporeal membrane oxygenation (VA-ECMO) therapy. We suggest that for patients with severe myocardial injury complicated with cardiogenic shock following AOPP, the use of VA-ECMO therapy can improve the prognosis.
BibTeX
@inproceedings{li2020successful,
  author = {Yang Li and Chunshui Cao and Xiaolong Luo and Huang Liang},
  title = {{Successful Treatment of Severe Myocardial Injury Complicated With Refractory Cardiogenic Shock Caused by AOPP Using Extracorporeal Membrane Oxygenation}},
  booktitle = {Research},
  year = {2020},
  doi = {10.21203/rs.3.rs-104375/v1},
}

Loading related content...

Figure